JEFFREY SPENCER: Open Payments
NPI 1568982353 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 43 payments from 14 companies in 2025. Trend: 2023 $395 · 2024 $1,115 · 2025 $1,171
Food & beverage: $1,171
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 7 | $206 |
| AERIN MEDICAL INC. | 1 | $144 |
| Paratek Pharmaceuticals, Inc. | 2 | $142 |
| CSL Behring | 7 | $137 |
| Regeneron Healthcare Solutions, Inc. | 5 | $118 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| JAZZ PHARMACEUTICALS INC. | 3 | $73 |
| GENZYME CORPORATION | 3 | $72 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $40 |
Products named: XHANCE, DUPIXENT, VIVAER STYLUS, Hizentra, NUZYRA, NUCALA, XYWAV, Sunosi.
Industry payments across NY — which companies pay providers there.
